Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China

Table 4 Logistic regression analyses between BRAF V600E mutation group and BRAF V600E wild group

Index	β	SE	Wals	Sig.	HR	95%CI
Index	β	SE	Wals	Sig.	HR	upper	lower
Lymph node metastasis	−2.363	0.526	20.154	< 0.001	0.094	0.034	0.264
¹³¹I radiotherapy	2.032	0.526	14.930	< 0.001	7.628	2.721	21.378
Pathology (PTC/PTMC)	−0.418	0.334	1.564	0.211	0.659	0.342	1.267

ISSN: 1746-1596